Tech Titans: Amazon, Nvidia, AMD, and TSM Dominate Evercore ISI's Picks

  tech-titans-amazon-nvidia-amd-and-tsm-dominate-evercore-isi-s-picks.html
  Stocks and Investing on Thu, Jan 08th, 2026 by CNBC
      Locale: UNITED STATES

The Tech Titans: Amazon, Nvidia, AMD, and Taiwan Semiconductor Manufacturing (TSM)

The tech sector unsurprisingly dominates Evercore ISI's list, reflecting the ongoing digital transformation reshaping the global economy. Amazon (AMZN) remains a cornerstone, and the analysts' focus isn't solely on e-commerce. While still a significant contributor, Amazon Web Services (AWS) is highlighted as a key driver of future growth. AWS continues to expand its cloud services, capturing an ever-larger share of the market. Furthermore, Amazon's burgeoning healthcare initiatives and continued dominance in online advertising contribute to its long-term potential.

Following closely behind, Nvidia (NVDA) is predicted to enjoy sustained demand. The artificial intelligence boom is undeniable, and Nvidia's specialized chips are essential for powering this technological revolution. However, Evercore ISI also recognizes the potential for increased competition. This is where Advanced Micro Devices (AMD) enters the picture. The analysts foresee AMD capitalizing on a potential slowdown in Nvidia's growth, leveraging its competitive advantage to secure market share and drive profitability.

The backbone of the chip industry, Taiwan Semiconductor Manufacturing (TSM), is also deemed a top pick. As the world's leading contract chip manufacturer, TSM's facilities are crucial for producing chips for companies like Nvidia and AMD. Increasing global demand for semiconductors almost guarantees a strong performance from TSM.

Healthcare Heavyweights: Eli Lilly, Vertex, and UnitedHealth Group (UNH)

The healthcare sector represents a significant portion of Evercore ISI's selections, indicating a belief in the continued strength and growth potential of this industry. Eli Lilly (LLY) is positioned to continue its leadership in the diabetes and weight loss markets, fueled by ongoing research and development and escalating consumer demand. The company's scientific breakthroughs provide a clear path to sustained profitability.

Vertex Pharmaceuticals (VRTX) stands out due to its promising pipeline of therapies. A robust pipeline suggests a future stream of revenue and growth potential, making it an attractive investment. Similarly, UnitedHealth Group (UNH) is expected to capitalize on the ongoing rise in healthcare costs and the consistently strong consumer demand for medical services. While challenges exist within the healthcare landscape, UNH's scale and diversified services position it to navigate them effectively.

Value and Renewables: Costco and NextEra Energy (NEE)

Beyond technology and healthcare, Evercore ISI's picks highlight the importance of value and sustainability. Costco (COST)'s membership-based retail model proves resilient even during economic uncertainty. Its focus on providing value to customers fosters loyalty and consistent revenue. Finally, NextEra Energy (NEE), a leading player in the renewable energy sector, is expected to flourish alongside the global shift towards sustainable power sources. Investments in renewable assets position NextEra for long-term growth.

The mRNA Potential: Moderna (MRNA)

Rounding out the list is Moderna (MRNA). While initially known for its COVID-19 vaccines, Moderna's mRNA technology holds far broader applications. Evercore ISI believes the company has a significant runway for growth as it explores treatments for a wider range of diseases, solidifying its position as an innovator in the biotechnology space.

Conclusion

Evercore ISI's 2026 stock picks demonstrate a thoughtful analysis of current market trends and future opportunities. The selection reveals a belief in the power of technological innovation, the resilience of the healthcare sector, the value of consistent consumer experiences, and the importance of sustainable energy. While all investments carry risk, these picks reflect a compelling investment thesis based on robust fundamentals and promising growth prospects for the coming year.